Robert Berman
Directeur/Membre du Conseil chez SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II
Profil
Robert Berman was the founder of Biohaven Pharmaceuticals, Inc., which was founded in 2013, where he held the title of Chief Medical Officer from 2013 to 2019.
Currently, he is an Independent Director at Social Capital Suvretta Holdings Corp.
II, where he started in 2022.
Dr. Berman received his undergraduate degree from Yale University and another undergraduate degree from Icahn School of Medicine at Mount Sinai in 1990.
Postes actifs de Robert Berman
| Sociétés | Poste | Début |
|---|---|---|
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Directeur/Membre du Conseil | 29/06/2022 |
Anciens postes connus de Robert Berman
| Sociétés | Poste | Fin |
|---|---|---|
Biohaven Pharmaceuticals, Inc.
 Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Fondateur | 01/01/2019 |
Formation de Robert Berman
| Yale University | Undergraduate Degree |
| Icahn School of Medicine at Mount Sinai | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. II | Finance |
| Entreprise privées | 1 |
|---|---|
Biohaven Pharmaceuticals, Inc.
Biohaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Biohaven Pharmaceuticals, Inc. engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. The company in July 2013 and is headquartered in New Haven, CT. | Commercial Services |
